These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 19480105
1. Paget's disease of bone and osteonecrosis. Seehra J, Sloan P, Oliver RJ. Dent Update; 2009 Apr; 36(3):166-8, 171-2. PubMed ID: 19480105 [Abstract] [Full Text] [Related]
2. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws. Gueiros LA, Lopes MA, Leão JC. J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809 [No Abstract] [Full Text] [Related]
3. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws. Gallego L, Junquera L. Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371 [Abstract] [Full Text] [Related]
4. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications. Hay KD, Bishop PA. N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881 [Abstract] [Full Text] [Related]
6. [Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature]. Bornstein MM, Oberli K, Stauffer E, Buser D. Schweiz Monatsschr Zahnmed; 2006 Mar; 116(10):1035-47. PubMed ID: 17078515 [Abstract] [Full Text] [Related]
8. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. Melo MD, Obeid G. J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429 [Abstract] [Full Text] [Related]
9. Residual (ghost) sockets in bisphosphonate use--evidence of poor healing and slow bone turnover. Shetty K, Bouquot J. Gen Dent; 2009 Feb; 57(2):130-5. PubMed ID: 19552362 [Abstract] [Full Text] [Related]
11. Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease. Watts MR, Ellims AH, Eccleston DS. Med J Aust; 2014 Feb 17; 200(3):150. PubMed ID: 24528425 [No Abstract] [Full Text] [Related]
13. Suppurative maxillary sinusitis in patients with bisphosphonate-associated osteonecrosis of the maxilla: report of 2 cases. Koulocheris P, Weyer N, Liebehenschel N, Otten JE, Gutwald R, Schmelzeisen R. J Oral Maxillofac Surg; 2008 Mar 17; 66(3):539-42. PubMed ID: 18280390 [No Abstract] [Full Text] [Related]
15. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. J Oral Pathol Med; 2005 Nov 17; 34(10):613-7. PubMed ID: 16202082 [Abstract] [Full Text] [Related]
17. Persistent effect of zoledronic acid in Paget's disease. Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F. Clin Exp Rheumatol; 2007 Nov 17; 25(3):464-6. PubMed ID: 17631747 [Abstract] [Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Grewal VS, Fayans EP. Todays FDA; 2008 Aug 17; 20(8):38-41, 43-6. PubMed ID: 18767452 [Abstract] [Full Text] [Related]
19. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone. Keating GM, Scott LJ. Drugs; 2007 Aug 17; 67(5):793-804. PubMed ID: 17385948 [Abstract] [Full Text] [Related]
20. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants]. Savoldelli C, Le Page F, Santini J, Scortecci G, Odin G. Rev Stomatol Chir Maxillofac; 2007 Dec 17; 108(6):555-8. PubMed ID: 17631371 [Abstract] [Full Text] [Related] Page: [Next] [New Search]